海外中药发展现状及产业链控制思考

Development status of overseas Chinese material medica and thinking of industrial chain control

开发优质中药是中药现代化、国际化发展的前提,而中药全产业链控制保障了中药从种子、药材、饮片、制剂到成品的质量。近年来海外进口中药材大量涌入国内市场,但其中往往存在基原不详、真伪夹杂等现象,导致中药疗效不稳定,加上引种困难、药材进口成本加大等问题,这些都不利于中药发展。进行海外中药产业链控制,建设中药规范化生产基地、推行中药本土化研究、对外输出中医药人才等举措将对于推进“一带一路”中医药大健康产业大有裨益。

The development of good quality Chinese material medica is the prerequisite for the modernization and internationalization of Chinese material medica.The whole industrial chain control ensures the quality for seeds,crude herbs,pieces,preparations and finished products of Chinese material medica.In recent years,a large number of imported Chinese medicinal materials imported from overseas have flooded into the domestic market,but there are often some problems such as unknown origin,mixed authenticity and so on,leading to the unstable efficacy of Chinese material medica,and the problems of introduction difficulty and higher import cost make things worse to the development of Chinese material medica.The following methods of controlling the overseas Chinese material medica industry chain,the construction of standardized base of Chinese material medica,carrying out the localization research of Chinese material medica and traditional Chinese medicine talent output will be of great benefit,which will promote“The Belt and Road”comprehensive health industry of traditional Chinese medicine.